Nicotine addiction and nicotinic receptors: lessons from genetically modified mice
The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
Abstract
The past decades have seen a revolution in our understanding of brain diseases and in particular of drug addiction. This has been largely due to the identification of neurotransmitter receptors and the development of animal models, which together have enabled the investigation of brain functions from the molecular to the cognitive level. Tobacco smoking, the principal - yet avoidable - cause of lung cancer is associated with nicotine addiction. Recent studies in mice involving deletion and replacement of nicotinic acetylcholine receptor subunits have begun to identify the molecular mechanisms underlying nicotine addiction and might offer new therapeutic strategies to treat this addiction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These receptors appear early in development and are functionally active in the fetal brain to mediate many critical aspects of brain maturation [1–4].”
From Nicotine on the developing brain. (2023) · cites this paper as [1]
In the citing paper
“Nicotine, the primary psychoactive component of tobacco, activates nicotinic acetylcholine receptors (nAChRs), pentameric ligand-gated ion channels which are widely distributed throughout the brain [1,2].”
From Nicotine on the developing brain. (2023) · cites this paper as [1]
In the citing paper
“Nicotine usurps the action of endogenous acetylcholine (ACh) by signaling through nicotinic acetylcholine receptors (nAChRs), a diverse family of pentameric ligand-gated cation channels [52].”
From Adolescent nicotine exposure and persistent neurocircuitry changes: unveiling lifelong psychiatric risks (2025) · cites this paper as [52]
In the citing paper
“The primary nAChRs in CNS dopaminergic systems that mediate the addictive effects of nicotine are the ␣42* and ␣62* subtypes”
From Varenicline Is a Potent Partial Agonist at α6β2* Nicotinic Acetylcholine Receptors in Rat and Monkey Striatum (2012) · cites this paper as Changeux, 2010
In the citing paper
“a region implicated in the rewarding and addictive effects of nicotine (Wise, 2009;Changeux, 2010).”
From Varenicline Is a Potent Partial Agonist at α6β2* Nicotinic Acetylcholine Receptors in Rat and Monkey Striatum (2012) · cites this paper as Changeux, 2010
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
Everitt, B. J., & Robbins, T. W. (2005) · Nature Neuroscience · doi:10.1038/nn1579 · Cited by 3,785
Getting formal with dopamine and reward
Schultz, W. (2002) · Neuron · doi:10.1016/s0896-6273(02)00967-4 · Cited by 2,574
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,464
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
The prefontral cortex and cognitive control
Miller, E. K. (2000) · Nature Reviews Neuroscience · doi:10.1038/35036228 · Cited by 2,016
Seguela, P., Wadiche, J., Dineley-Miller, K., Dani, J., & Patrick, J. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-02-00596.1993 · Cited by 1,471
A study of the ‘desensitization’ produced by acetylcholine at the motor end‐plate
Katz, B., & Thesleff, S. (1957) · The Journal of Physiology · doi:10.1113/jphysiol.1957.sp005838 · Cited by 1,461
The control of firing pattern in nigral dopamine neurons: burst firing
Grace, A., & Bunney, B. (1984) · The Journal of Neuroscience · doi:10.1523/jneurosci.04-11-02877.1984 · Cited by 1,344
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Self-citationLateral habenula as a source of negative reward signals in dopamine neurons
Matsumoto, M., & Hikosaka, O. (2007) · Nature · doi:10.1038/nature05860 · Cited by 1,292
Research works printed but not linked: 1
- Tolu, S. et al. A versatile system for the neuronal subtype specific expression of lentiviral vectors. FENS Forum of European Neuroscience (Amsterdam, the Netherlands). Abstract 07549 (2010).
Cited by
Experimental and theoretical approaches to conscious processing
Dehaene, S., & Changeux, J.-P. (2011) · Neuron · doi:10.1016/j.neuron.2011.03.018 · Cited by 2,573
Self-citationWitten, I. B., Steinberg, E. E., Lee, S. Y., Davidson, T. J., Zalocusky, K. A., Brodsky, M., Yizhar, O., Cho, S. L., Gong, S., Ramakrishnan, C., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.10.028 · Cited by 680
Sofouglu, M., Herman, A. I., Robinson, C. D., & Waters, A. J. (2014) · Lincoln (University of Nebraska) · Cited by 417
Use of rodents as models of human diseases
Vandamme, T. (2014) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.124301 · Cited by 389
“[55] Arachidonic acid metabolism and central nervous system pathology Bosetti used genetic mouse models to investigate the physiological and pathological roles of Arachidonic acid (AA) release and metabolism in brain.”
Ren, J., Qin, C., Hu, F., Tan, J., Qiu, L., Zhao, S., Feng, G., & Luo, M. (2011) · Neuron · doi:10.1016/j.neuron.2010.12.038 · Cited by 315
“Behaviorally, it is suggested to be involved in sleep, stress, pain, and nicotine addiction (Changeux, 2010; Haun et al., 1992; Hikosaka, 2010; Plenge et al., 2002; Salas et al., 2009; Sandyk, 1991).”
BackgroundFrahm, S., Ślimak, M. A., Ferrarese, L., Santos-Torres, J., Antolin-Fontes, B., Auer, S., Filkin, S., Pons, S., Fontaine, J.-F., Tsetlin, V., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.04.013 · Cited by 283
“…brain regions, including the prefrontal cortex, VTA, thalamus, striatum and amygdala are affected by chronic use of nicotine, the habenular system is emerging as an important station in pathways regulating the behavioral effects of nicotine (Changeux, 2010; De Biasi and Salas, 2008; Rose, 2007).”
A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications
Changeux, J.-P., Amoura, Z., Rey, F. A., & Miyara, M. (2020) · Comptes Rendus. Biologies · doi:10.5802/crbiol.8 · Cited by 289
Self-citationDiversity of native nicotinic receptor subtypes in mammalian brain
Zoli, M., Pistillo, F., & Gotti, C. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.003 · Cited by 277
“1B) (Gotti et al., 2009; Changeux, 2010a).”
InfluentialCognitive Effects of Nicotine: Recent Progress
Valentine, G., & Sofuoglu, M. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666171103152136 · Cited by 271
“These include improved knowledge about the role of the nicotinic acetylcholine receptor (nAChR) in cognitive function and reinforcement [20, 21], the localization of the brain regions that mediate nicotine’s effects on cognitive function [22], and the role of specific subtypes of nAChR in cognitive enhancement, most n…”
Backgroundα6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson’s Disease
Quik, M., & Wonnacott, S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003269 · Cited by 192
Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use
Taylor, C. P., Traynelis, S. F., Siffert, J., Pope, L. E., & Matsumoto, R. R. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.04.010 · Cited by 186
Recent advances in the genetic epidemiology and molecular genetics of substance use disorders
Kendler, K. S., Chen, X., Dick, D., Maes, H., Gillespie, N., Neale, M. C., & Riley, B. (2012) · Nature Neuroscience · doi:10.1038/nn.3018 · Cited by 179
“Some other lessons can be tentatively learned from the CHRNA5–CHNRA3–CHRNB4 locu”
BackgroundDo initial responses to drugs predict future use or abuse?
de Wit, H., & Phillips, T. J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.04.005 · Cited by 176
“Recent reviews (Changeux, 2010; Tuesta et al., 2011) nicely detail current knowledge about the involvement of specific nicotinic receptor subtypes, signaling mechanisms and brain locations in nicotine, as well as other drug, self-administration behavior, but does not touch on the topic of initial sensitivity.”
Wassenaar, C. A., Dong, Q., Wei, Q., Amos, C. I., Spitz, M. R., & Tyndale, R. F. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr237 · Cited by 174
“CYP2A6 inactivates nicotine and also activates tobacco-specific nitrosamines (1,7), whereas nicotinic receptors mediate nicotine-induced reward (8) and nitrosamine-induced carcinogenic signaling (9).”
Beyond the Channel: Metabotropic Signaling by Nicotinic Receptors
Kabbani, N., & Nichols, R. A. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.01.002 · Cited by 169
“Genes encoding a (a2–a10) and b (b2–b4) subunits have been identified in the mammalian brain, and a large proportion of these are expressed at the synapse [9,10].”
BackgroundDiversity of Dopaminergic Neural Circuits in Response to Drug Exposure
Juarez, B., & Han, M.-H. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.32 · Cited by 165
“VTA DA neurons express primarily α2–α7 and β2–β4 subunits (Klink et al, 2001; Pidoplichko et al, 1997). β2-containing nAChRs in VTA DA neurons have a high affinity for nicotine, a long desensitization rate and exhibit a strong upregulation during chronic nicotine exposure (Changeux, 2010).”
BackgroundExley, R., Maubourguet, N., David, V., Eddine, R., Evrard, A., Pons, S., Marti, F., Threlfell, S., Cazala, P., McIntosh, J. M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103000108 · Cited by 159
“The underlying neurobiological mechanisms of addiction are complex (2), and further work is required to identify novel smoking cessation targets (3).”
BackgroundPicciotto, M. R., Lewis, A. S., van Schalkwyk, G. I., & Mineur, Y. S. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.028 · Cited by 157
Gergalova, G., Lykhmus, O., Kalashnyk, O., Koval, L., Чернышов, В. И., Kryukova, E. V., Tsetlin, V. I., Комісаренко, С. В., & Skok, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031361 · Cited by 164
“In the brain, they regulate glutamate-, GABAand dopamine-mediated transmission and are involved in the establishment of nicotine dependence [2].”
BackgroundThe habenulo-interpeduncular pathway in nicotine aversion and withdrawal
Antolin-Fontes, B., Ables, J. L., Görlich, A., & Ibañez-Tallon, I. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.019 · Cited by 154
“Within the MHb, only neurons in the MHbVl contain the a4* nAChRs, which are among the most sensitive receptors to nicotine and ACh (Chavez-Noriega et al., 1997; Gotti et al., 2009; Kuryatov et al., 2008), but likely do not express ChAT (Shih et al., 2014).”
BackgroundCo-activation of VTA DA and GABA neurons mediates nicotine reinforcement
Tolu, S., Eddine, R., Marti, F., David, V, Graupner, M., Pons, S., Baudonnat, M., Husson, M., Besson, M., Reperant, C., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.83 · Cited by 151
Self-citationSmoking during pregnancy affects foetal brain development
Ekblad, M. O., Korkeila, J. J. A., & Lehtonen, L. (2014) · Acta Paediatrica · doi:10.1111/apa.12791 · Cited by 324
“The nicotinic acetylcholine receptors (nAChRs) are crucial during foetal brain development, as they modulate axonal pathfinding, synapse formation and cell survival (12,13).”
BackgroundNicotine on the developing brain.
Castro, E. M., Lotfipour, S., & Leslie, F. M. (2023) · Pharmacological research · doi:10.1016/j.phrs.2023.106716 · Cited by 157
Nicotine inhibits the VTA-to-amygdala dopamine pathway to promote anxiety
Nguyen, C., Mondoloni, S., Le Borgne, T., Centeno, I., Come, M., Jehl, J., Solié, C., Reynolds, L. M., Durand-de Cuttoli, R., Tolu, S., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.06.013 · Cited by 136
The desensitization gate of inhibitory Cys-loop receptors
Gielen, M. C., Thomas, P., & Smart, T. G. (2015) · Nature Communications · doi:10.1038/ncomms7829 · Cited by 142
Glutamatergic Synapse Formation is Promoted by α7-Containing Nicotinic Acetylcholine Receptors
Lozada, A. F., Wang, X., Gounko, N. V., Massey, K. A., Duan, J., Liu, Z., & Berg, D. K. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6246-11.2012 · Cited by 152
“While 2*-nAChRs represent a major class of nicotinic receptors in the CNS, comparable in number to 7-nAChRs (Albuquerque et al., 2009; Gotti et al., 2009; Changeux, 2010), they do not appear to be required for glutamatergic synapse formation.”
BackgroundRegulation of cholinergic activity by the vesicular acetylcholine transporter
Prado, V. F., Roy, A., Kolisnyk, B., Gros, R., & Prado, M. A. M. (2013) · Biochemical Journal · doi:10.1042/bj20121662 · Cited by 151
Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk
Kabbani, N., & Olds, J. L. (2020) · Molecular Pharmacology · doi:10.1124/molpharm.120.000014 · Cited by 142
“Notably, nAChRs are known to be on many of the same cells that express ACE2 in the lungs, kidneys, circulation, and brain (Changeux, 2010; Tolu et al., 2013; Nordman et al., 2014).”
BackgroundTowards a cognitive neuroscience of self-awareness
Lou, H. C., Changeux, J. P., & Rosenstand, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.04.004 · Cited by 131
Self-citationZebrafish: a model for the study of addiction genetics
Klee, E. W., Schneider, H., Clark, K. J., Cousin, M. A., Ebbert, J. O., Hooten, W. M., Karpyak, V. M., Warner, D. O., & Ekker, S. C. (2011) · Human Genetics · doi:10.1007/s00439-011-1128-0 · Cited by 139
“Detailed reviews addressing nAChR subtype structures and the associated binding properties of nicotine have been published (Changeux 2010; Gotti et al. 2007; 2006; Karlin 2002; Rucktooa et al. 2009).”
BackgroundRole of nicotinic acetylcholine receptors in regulating dopamine neuron activity
Faure, P., Tolu, S., Valverde, S., & Naudé, J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.05.040 · Cited by 125
Kolisnyk, B., Guzmán-Lenis, M.-S., Raulic, S., Fan, J., Magalhães, A. C., Feng, G., Gros, R., Prado, V. F., & Prado, M. A. M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0395-13.2013 · Cited by 129
“Genetic approaches have been used to determine the specific roles of ACh in different brain regions (Guzman et al., 2011; Martyn et al., 2012; Patel et al., 2012), as well as to pinpoint precise functions of ACh receptors (for review, see Wess et al., 2007; Changeux, 2010).”
BackgroundMethodNicotine consumption is regulated by a human polymorphism in dopamine neurons
Morel, C., Fattore, L., Pons, S., Hay, Y. A., Marti, F., Lambolez, B., De Biasi, M., Lathrop, M., Fratta, W., Maskos, U., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.158 · Cited by 123
Young, J. W., & Geyer, M. A. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.06.031 · Cited by 139
“nAChRs are ligand-gated ion channels, existing as combinations from a family of similar but distinct subunits a1–a10, b1–4, g, d, and e [32,33].”
Cigarette smoking, cyclooxygenase-2 pathway and cancer
Huang, R.-Y., & Chen, G. Y. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.11.005 · Cited by 125
“Moreover, nicotine is conceived to be a formidable obstacle to the prevention of smoke-induced deaths since it is a highly addictive ingredient of cigarette smoke [60].”
BackgroundMolecules and circuits involved in nicotine addiction: The many faces of smoking
Picciotto, M. R., & Mineur, Y. S. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.028 · Cited by 129
Checks and balances on cholinergic signaling in brain and body function
Soreq, H. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.05.007 · Cited by 129
“neuronal nAChRs comprise heteromeric pentamers [3], except for the a7 homomeric pentamers.”
BackgroundInfluentialPrefrontal nicotinic receptors control novel social interaction between mice
Avale, M. E., Chabout, J., Pons, S., Serreau, P., De Chaumont, F., Olivo‐Marin, J., Bourgeois, J., Maskos, U., Changeux, J., & Granon, S. (2011) · The FASEB Journal · doi:10.1096/fj.10-178558 · Cited by 114
Self-citationPistillo, F., Clementi, F., Zoli, M., & Gotti, C. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.10.002 · Cited by 134
“3) (reviewed in Livingstone and Wonnacott, 2009; Changeux, 2010; Stoker and Markou, 2013).”
InfluentialGörlich, A., Antolin‐Fontes, B., Ables, J. L., Frahm, S., Ślimak, M. A., Dougherty, J. D., & Ibáñez-Tallon, I. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313103110 · Cited by 126
“Upon nicotine cessation in humans, a withdrawal syndrome—characterized by negative somatic and affective symptoms such as irritability, anxiety, depressed mood, and loss of concentration—develops (2, 3) and contributes to the high probability of smoking relapse.”
BackgroundInfluentialModeling human neurodegenerative diseases in transgenic systems
Sosa, M. A. G., Gasperi, R. D., & Elder, G. A. (2011) · Human Genetics · doi:10.1007/s00439-011-1119-1 · Cited by 125
King, J. R., Nordman, J. C., Bridges, S. P., Lin, M., & Kabbani, N. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.647040 · Cited by 107
“Nicotinic acetylcholine receptors (nAChRs)(2) comprise an important class of the Cys-loop ligand-gated ion channel superfamily, which mediate communication between neurons by conversion of chemical neurotransmitter signals into a transmembrane flux of ions (1).”
BackgroundMethodWang, J., Yuan, W., & Li, M. D. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8202-4 · Cited by 106
Smith, J. S., Schindler, A. G., Martinelli, E., Gustin, R. M., Bruchas, M. R., & Chavkin, C. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2980-11.2012 · Cited by 102
“Despite widespread knowledge of the health risks associated with tobacco consumption (Changeux, 2010), 10% of smokers who attempt to quit each year are successful, and tobacco relapse rates remain high despite current nicotine dependence treatments (Benowitz, 2008).”
BackgroundGardon, O., Faget, L. C., Chung, P. C. S., Matifas, A., Massotte, D., & Kieffer, B. L. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.07.053 · Cited by 118
“Indeed the laterodorsal tegmental area (LDTg) and the pedunculopontine tegmental area (PPTg), both part of the dorsal tegmental area, send projections to the VTA dopaminergic neurons and influence their firing (Lodge and Grace, 2006, Changeux, 2010, Norton et al., 2011).”
BackgroundIs nicotine exposure linked to cardiopulmonary vulnerability to COVID‐19 in the general population?
Olds, J. L., & Kabbani, N. (2020) · FEBS Journal · doi:10.1111/febs.15303 · Cited by 105
An essential role of acetylcholine-glutamate synergy at habenular synapses in nicotine dependence
Frahm, S., Antolin-Fontes, B., Görlich, A., Zander, J.-F., Ahnert-Hilger, G., & Ibañez-Tallon, I. (2015) · eLife · doi:10.7554/elife.11396 · Cited by 98
“Tolerance to nicotine and withdrawal severity are both critical for the development and maintenance of dependence in humans and animal models (Changeux, 2010; West et al., 1989).”
BackgroundThe neurobiological and behavioral overlaps of nicotine and food addiction
Criscitelli, K., & Avena, N. M. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.08.009 · Cited by 101
Fowler, C. D., & Kenny, P. J. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.05.012 · Cited by 109
Quik, M., Perez, X. A., & Grady, S. R. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.001 · Cited by 105
Parikh, V., Kutlu, M. G., & Gould, T. J. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.01.020 · Cited by 106
Augmentation of Extinction and Inhibitory Learning in Anxiety and Trauma-Related Disorders
Lebois, L. A. M., Seligowski, A. V., Wolff, J. D., Hill, S. B., & Ressler, K. J. (2019) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050718-095634 · Cited by 103
“The nicotinic receptors are made up of five subunits and are permeable to sodium, potassium, and calcium depending on the particular subunit composition (Changeux 2010).”
An immune-beige adipocyte communication via nicotinic acetylcholine receptor signaling
Jun, H., Yu, H. M., Gong, J., Jiang, J., Qiao, X., Perkey, E., Kim, D., Emont, M. P., Zestos, A. G., Cho, J.-S., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0032-8 · Cited by 94
“The nAChRs belong to a large superfamily of ligand-gated ion channels that are expressed throughout both the central and the peripheral nervous systems, as well as in non-neuronal cell populations 11,12 .”
Grimster, N. P., Stump, B., Fotsing, J. R., Weide, T., Talley, T. T., Yamauchi, J. G., Nemecz, Á., Kim, C., Ho, K., Sharpless, K. B., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3001858 · Cited by 91
Koval, L., Lykhmus, O., Zhmak, M. N., Khruschov, A. Y., Tsetlin, V. I., Magrini, E. I., Viola, A., Chernyavsky, A. I., Qian, J., Grando, S. A., et al. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.12.003 · Cited by 90
Anatomy and Function of Ventral Tegmental Area Glutamate Neurons
Cai, J., & Tong, Q. (2022) · Frontiers in Neural Circuits · doi:10.3389/fncir.2022.867053 · Cited by 112
“The expression of β2-containing nAChRs has been detected in VTA DA neurons (Klink et al., 2001; Changeux, 2010), and the nicotine treatment promotes VTA DA release (Mansvelder and Mcgehee, 2002).”
BackgroundAltered resting state functional connectivity of anterior insula in young smokers
Bi, Y., Yuan, K., Guan, Y., Cheng, J., Zhang, Y., Li, Y., Yu, D., Qin, W., & Tian, J. (2016) · Brain Imaging and Behavior · doi:10.1007/s11682-016-9511-z · Cited by 95
Ignatowska-Jankowska, B. M., Muldoon, P. P., Lichtman, A. H., & Damaj, M. I. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3117-6 · Cited by 89
“, habenula), that indirectly regulate DA release in NAc (Changeux 2010; Baldwin et al. 2011; McCallum et al. 2012).”
BackgroundInfluentialHigh density of nicotinic receptors in the cingulo-insular network
Picard, F., Sadaghiani, S., Leroy, C., Courvoisier, D. S., Maroy, R., & Bottlaender, M. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.04.074 · Cited by 89
“While a large literature has involved the nAChRs in addiction (Brody, 2006; Changeux, 2010; Li and Burmeister, 2009), the insula has been proposed as a key structure in addiction since 2007.”
BackgroundNicotine and endogenous opioids: neurochemical and pharmacological evidence
Hadjiconstantinou, M., & Neff, N. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.11.010 · Cited by 81
Nicotinic acetylcholine receptor redux: Discovery of accessories opens therapeutic vistas
Matta, J. A., Gu, S., Davini, W. B., & Bredt, D. S. (2021) · Science · doi:10.1126/science.abg6539 · Cited by 82
The "Stop" and "Go" of Nicotine Dependence: Role of GABA and Glutamate
D’Souza, M. S., & Markou, A. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012146 · Cited by 83
Igari, M., Alexander, J. C., Ji, Y. R., Qi, X., Papke, R. L., & Bruijnzeel, A. W. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.216 · Cited by 78
“There is extensive evidence for a role of a4b2* nAChRs in dysphoric-and anxiety-like behavior associated with nicotine withdrawal (Picciotto and Kenny, 2013; Changeux, 2010).”
BackgroundBesson, M., & Forget, B. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00160 · Cited by 87
Hopkins, T. J., Rupprecht, L. E., Hayes, M. R., Blendy, J. A., & Schmidt, H. D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.83 · Cited by 75
“Although a growing body of evidence indicates that enhanced cholinergic signaling is critically involved in nicotine addiction (Changeux, 2010; De Biasi and Dani, 2011; Tuesta et al, 2011), a potential role for acetylcholinesterase in the reinforcing effects of nicotine and the reinstatement of…”
BackgroundZebrafish for the Study of the Biological Effects of Nicotine
Klee, E. W., Ebbert, J. O., Schneider, H., Hurt, R. D., & Ekker, S. C. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr010 · Cited by 76
“The use of rodent models has been expertly reviewed elsewhere (Changeux, 2010; O’Dell & Khroyan, 2009; Zaniewska, Przegaliński, & Filip, 2009).”
MethodBordia, T., Hrachova, M., Chin, M., McIntosh, J. M., & Quik, M. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.194852 · Cited by 70
“…nAChRs in CNS dopaminergic systems that mediate the addictive effects of nicotine are the 4 2* and 6 2* subtypes (the asterisk indicates the possible presence of other subunits in the receptor complex) (Barik and Wonnacott, 2009; Changeux, 2010; Mao and McGehee, 2010; De Biasi and Dani, 2011).”
BackgroundKing, J. R., & Kabbani, N. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13660 · Cited by 71
Luchicchi, A., Bloem, B., Viaña, J. N. M., Mansvelder, H. D., & Role, L. W. (2014) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2014.00024 · Cited by 82
A caged nicotine with nanosecond range kinetics and visible light sensitivity
Filevich, O., Salierno, M. J., & Etchenique, R. (2010) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2010.08.003 · Cited by 68
Varenicline for smoking cessation: efficacy, safety, and treatment recommendations
Ebbert, J. O., Wyatt, K. D., Hays, J. T., Klee, E. W., & Hurt, R. D. (2010) · Patient Preference and Adherence · doi:10.2147/ppa.s10620 · Cited by 88
Modulation of dopamine release in the striatum by physiologically relevant levels of nicotine
Wang, L., Shang, S., Kang, X., Teng, S., Zhu, F., Liu, B., Wu, Q., Li, M., Liu, W. Y., Xu, H., et al. (2014) · Nature Communications · doi:10.1038/ncomms4925 · Cited by 74
An α7 nicotinic receptor-G protein pathway complex regulates neurite growth in neural cells*
Nordman, J. C., & Kabbani, N. (2012) · Journal of Cell Science · doi:10.1242/jcs.110379 · Cited by 82
“To date, 11 different nAChR subunits have been found in the mammalian brain (a2–a9 and b2–b4) (Albuquerque et al., 2009; Changeux, 2010).”
BackgroundThe Oncogenic Functions of Nicotinic Acetylcholine Receptors
Zhao, Y. (2016) · Journal of Oncology · doi:10.1155/2016/9650481 · Cited by 66
“This seemingly contradictory observation could be explained as upregulation of (α3β2)2α5-nAChR in brain may dampen the nicotine responses mediated by α7-nAChR and consequently leads to reduced dopamine release upon nicotine induction [26].”
BackgroundCuttoli, R. D.-D., Mondoloni, S., Marti, F., Lemoine, D., Nguyen, C., Naudé, J., d’Izarny-Gargas, T., Pons, S., Maskos, U., Trauner, D. H., et al. (2018) · eLife · doi:10.7554/elife.37487 · Cited by 77
“They are also present on DAergic terminals in the Nucleus Accumbens (NAc) and the prefrontal cortex (Grady et al., 2007; Changeux, 2010).”
BackgroundIon channels gated by acetylcholine and serotonin: structures, biology, and drug discovery
Wu, Z., Cheng, H. D., Jiang, Y., Melcher, K., & Xu, H. E. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.66 · Cited by 78
Collo, G., Bono, F., Cavalleri, L., Plebani, L., Mitola, S. M. F., Pich, E. M., Millan, M. J., Zoli, M., Maskos, U., Spano, P., et al. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.084863 · Cited by 71
“These a4b2* nAChR regulatory effects on the mesencephalic DA system are critically involved in mediating the reinforcing properties of nicotine (Picciotto et al., 1998; Marubio et al., 2003; Changeux, 2010), evidence supported by the effects of the a4b2* nAChR partial agonist varenicline in humans andmice (Rollema et…”
BackgroundInfluentialInduction of Dendritic Spines by 2-Containing Nicotinic Receptors
Lozada, A. F., Wang, X., Gounko, N. V., Massey, K. A., Duan, J., Liu, Z., & Berg, D. K. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6247-11.2012 · Cited by 79
“Spine dependence on other paradigms (Besson et al., 2007), constitutive removal of the 2-nAChR gene does not apparently induce relevant compensatory changes in the levels of other nAChR subtypes (Albuquerque et al., 2009; Gotti et al., 2009; Changeux, 2010).”
BackgroundInfluentialBelief about nicotine selectively modulates value and reward prediction error signals in smokers
Gu, X., Lohrenz, T. M., Salas, R., Baldwin, P. R., Soltani, A., Kirk, U., Cinciripini, P. M., & Montague, P. R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416639112 · Cited by 67
“In rodent models, pharmacological intervention (42, 43), genetic modification (34), and optogenetic stimulation (44) have shown initial success in reversing drug-induced behavior by acting on DA signaling.”
BackgroundEffects of chronic low- and high-dose nicotine on cognitive flexibility in C57BL/6J mice
Ortega, L. A., Tracy, B. A., Gould, T. J., & Parikh, V. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.10.032 · Cited by 71
Getting a Handle on Neuropharmacology by Targeting Receptor-Associated Proteins
Maher, M. P., Matta, J. A., Gu, S., Seierstad, M., & Bredt, D. S. (2017) · Neuron · doi:10.1016/j.neuron.2017.10.001 · Cited by 64
Nicotinic receptors regulate the dynamic range of dopamine release in vivo
Koranda, J. L., Cone, J. J., McGehee, D. S., Roitman, M. F., Beeler, J. A., & Zhuang, X. (2013) · Journal of Neurophysiology · doi:10.1152/jn.00269.2013 · Cited by 74
Toxic effects of prenatal exposure to alcohol, tobacco and other drugs
Scott-Goodwin, A. C., Puerto, M., & Moreno, I. (2016) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.03.043 · Cited by 66
Koukouli, F., & Maskos, U. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.018 · Cited by 69
“Nicotine is the main psychoactive component of tobacco that leads to tobacco dependence, a major public health problem resulting in significant morbidity and mortality [88].”
BackgroundBehavioral and Molecular Analysis of Nicotine-Conditioned Place Preference in Zebrafish
Kedikian, X., Faillace, M. P., & Bernabeu, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069453 · Cited by 64
“Moreover, targeted genetic deletion of the a4 subunit from dopaminergic neurons increased sensitivity to nicotine-induced locomotor depression in mice [2].”
BackgroundDo Nicotinic Receptors Modulate High-Order Cognitive Processing?
Koukouli, F., & Changeux, J. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.06.001 · Cited by 70
“These deficits cause a compulsive selfadministration of drug with a loss of control (altered inhibition) and disrupted cognitive operations that impair judgment and favor relapse [5,110,111].”
Self-citationKing, J. R., Ullah, A., Bak, E., Jafri, M. S., & Kabbani, N. (2018) · Molecular Pharmacology · doi:10.1124/mol.117.111401 · Cited by 58
“Introduction Nicotinic acetylcholine receptors (nAChRs) are prototype cys-loop receptor channels with the ability to undergo ligandassociated structural changes that translate chemical signals to electrical information (Changeux, 2010).”
BackgroundA nicotinic hypothesis for Covid-19 with preventive and therapeutic implicationsPreprint
Changeux, J., Amoura, Z., Rey, F. A., & Miyara, M. (2020) · Comptes rendus. Biologies · doi:10.32388/fxgqsb.2 · Cited by 70
“One should not forget that nicotine is a drug of abuse [55] responsible for smoking addiction.”
BackgroundSelf-citationSevere acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
Uversky, V. N., Elrashdy, F., Aljaddawi, A. A., Ali, S. M., Khan, R. H., & Redwan, E. M. M. M. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24752 · Cited by 60
“Notably, nAChRs are found on the surfaces of many of the same cells that express ACE2 in the kidneys, lungs, circulation, and in the brain, and immune cells (Changeux, 2010; Nordman, Muldoon, et al., 2014; Nordman, Phillips, et al., 2014; Tolu et al., 2013).”
BackgroundLe, T. M., Potvin, S., Zhornitsky, S., & Li, C. R. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.04.028 · Cited by 64
Paulo, J. A., Gaun, A., & Gygi, S. P. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00398 · Cited by 63
Nicotinic receptor modulation to treat alcohol and drug dependence
Rahman, S., Engleman, E. A., & Bell, R. L. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00426 · Cited by 60
“Therefore, potential use of nAChR-based ligands and their ability to reverse some of these negative effects could improve impaired cognitive function of alcoholics and addicts and enhance the effectiveness of cognitive and behavioral therapies (Chatterjee and Bartlett, 2010).”
Giribaldi, J., & Dutertre, S. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.11.063 · Cited by 63
Besson, M., David, V., Baudonnat, M., Cazala, P., Guilloux, J., Repérant, C., Cloëz-Tayarani, I., Changeux, J., Gardier, A. M., & Granon, S. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2422-1 · Cited by 67
“Nevertheless, systemic nicotine admisnistration is very likely to involve additional nAChRs subtypes to cause its reinforcing effects (Changeux 2010).”
Self-citationScherma, M., Muntoni, A., Melis, M., Fattore, L., Fadda, P., Fratta, W., & Pistis, M. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4196-3 · Cited by 50
Recent Developments in Novel Antidepressants Targeting α4β2-Nicotinic Acetylcholine Receptors
Yu, L.-F., Zhang, H.-K., Caldarone, B. J., Eaton, J. B., Lukas, R. J., & Kozikowski, A. P. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401937a · Cited by 56
Nicotinic acetylcholine receptors: upregulation, age‐related effects and associations with drug use
Melroy-Greif, W. E., Stitzel, J. A., & Ehringer, M. A. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12251 · Cited by 62
“Nicotine is able to cross the blood–brain barrier and bind neuronal nAChRs in the brain (Clarke 1987), producing rewarding effects by interacting with nAChRs in the brain’s reward system (Changeux 2010).”
BackgroundAsis‐Cruz, J. D., Andescavage, N. N., & Limperopoulos, C. (2021) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2021.11.009 · Cited by 69
The α4 Nicotinic Receptor Promotes CD4+ T-Cell Proliferation and a Helper T-Cell Immune Response
Nordman, J. C., Muldoon, P. P., Clark, S. G., Damaj, M. I., & Kabbani, N. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.088484 · Cited by 53
“The molecular target of nicotine is a class of ligand-gated ion channels also activated by the endogenous neurotransmitter acetylcholine (Changeux, 2010).”
BackgroundNeurobiological Determinants of Tobacco Smoking in Schizophrenia
Lucatch, A. M., Lowe, D. J. E., Clark, R. C., Kozak, K., & George, T. P. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00672 · Cited by 61
Metadata
- Authors
- Changeux, J.-P.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Changeux, Jean-Pierre
- Venue
- Nature Reviews Neuroscience
- Published
- 2010-06
- Volume
- 11
- Issue
- 6
- Pages
- 389-401
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2014016697
- Cited by
- 453
- References
- 148
- Citations by year
- 2026: 17 · 2025: 17 · 2024: 14 · 2023: 16 · 2022: 23 · 2021: 21 · 2020: 30 · 2019: 23 · 2018: 29 · 2017: 25 · 2016: 32 · 2015: 36 · 2014: 47 · 2013: 34 · 2012: 44
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centre National de la Recherche Scientifique
- Ipsen
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- nicotine dependence, nicotinic acetylcholine receptors, nicotinic receptor subunits, transgenic mice, smoking, drug addiction
- MeSH terms
- Animals, Behavior, Animal, Central Nervous System, Disease Models, Animal, Humans, Mice, Transgenic, Models, Biological, Models, Molecular, Neural Pathways, Nicotine, Receptors, Nicotinic, Reward, Tobacco Use Disorder, Gene Expression, Protein Subunits, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.